Clinical use of meconium fatty acid ethyl esters for identifying children at risk for alcohol- related disabilities: The first reported case

Irene Zelner, Sarit Shor, Hazel Lynn, Henry Roukema, Lisa Lum, Kirsten Eisinga, Gideon Koren

نتاج البحث: نشر في مجلةمقالةمراجعة النظراء

12 اقتباسات (Scopus)

ملخص

Fatty acid ethyl esters (FAEEs) in meconium are validated biomarkers of heavy fetal alcohol exposure that may potentially be used clinically for identifying children at risk for alcohol-related disabilities. However, until now, FAEEs have been largely used anonymously in epidemiological studies, and by child protection authorities in need for verification of heavy alcohol use in pregnancy. Here we describe the first case of a neonate identified as part of a research study on a pilot neonatal screening program for prenatal alcohol exposure. The neonate's meconium tested high for FAEEs (52 nmol/g; positive cut-off ≥2 nmol/g), which prompted active follow-up of the infant's development, identifying early neurocognitive problems and allowing initiation of a remedial program.

اللغة الأصليةالإنجليزيّة
الصفحات (من إلى)26-31
عدد الصفحات6
دوريةJournal of Population Therapeutics and Clinical Pharmacology
مستوى الصوت19
رقم الإصدار1
حالة النشرنُشِر - 2012
منشور خارجيًانعم

بصمة

أدرس بدقة موضوعات البحث “Clinical use of meconium fatty acid ethyl esters for identifying children at risk for alcohol- related disabilities: The first reported case'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا